Keyword: Kevzara

French pharma group Sanofi abandons Covid-19 drug trials

Sanofi has announced that Kevzara, a drug originally developed with US pharma firm Regeneron for treating arthritis, has failed Phase 3 tests of its effectiveness in treating severe cases of Covid-19 and which involved 420 patients in several countries.

Related keywords